文献速递小儿耳鼻咽喉咽喉与嗓音

酮咯酸对儿童扁桃体切除术后出血再手术的影响:单中心回顾性倾向匹配研究

Impact of Ketorolac on Reoperation for Hemorrhage After Pediatric Tonsillectomy: A Single-Center Retrospective Propensity-Matched Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-11-05

该单中心回顾性倾向匹配研究纳入2015年1月1日至2020年10月1日接受扁桃体切除术或腺样体扁桃体切除术的18岁以下患者,比较围手术期使用酮咯酸(K+)与未使用(K-)患者30天和48小时内因出血再手术率。全队列5873例(42.1% K+),倾向匹配队列4694例;匹配队列中30天再手术率K+组1.9% vs K-组1.7%(OR 1.10,95%CI 0.72-1.69,P=0.662),48小时再手术率K+组0.68% vs K-组0.51%(OR 1.33,95%CI 0.63-2.81,P=0.451),均无显著差异。结论认为手术结束时使用酮咯酸可考虑作为儿童扁桃体切除术非阿片类镇痛方案的一部分。

要点

  • 倾向匹配队列中30天因出血再手术率K+组1.9% vs K-组1.7%,OR 1.10(95%CI 0.72-1.69,P=0.662),无显著差异。
  • 倾向匹配队列中48小时因出血再手术率K+组0.68% vs K-组0.51%,OR 1.33(95%CI 0.63-2.81,P=0.451),无显著差异。
  • 作者结论认为手术结束时使用酮咯酸可考虑作为儿童扁桃体切除术非阿片类镇痛方案的一部分。

核心结论

  • 围手术期使用酮咯酸与儿童扁桃体切除术后30天和48小时内因出血再手术率无显著关联。
  • 作者结论认为手术结束时使用酮咯酸可考虑作为儿童扁桃体切除术非阿片类镇痛方案的一部分。

研究设计与样本

  • 单中心回顾性倾向匹配研究,纳入2015年1月1日至2020年10月1日接受扁桃体切除术或腺样体扁桃体切除术的18岁以下患者。
  • 全队列5873例患者(42.1% K+),倾向匹配队列4694例患者。
  • 分析包括多变量逻辑回归、ASA 1和2患者亚组分析、儿童与青少年比较亚组分析。

主要发现

  • 全队列30天因出血再手术率K+组1.9% vs K-组1.6%(P=0.455)。
  • 倾向匹配队列30天因出血再手术率K+组1.9% vs K-组1.7%(OR 1.10,95%CI 0.72-1.69,P=0.662)。
  • 全队列48小时因出血再手术率K+组0.65% vs K-组0.53%(P=0.679)。
  • 倾向匹配队列48小时因出血再手术率K+组0.68% vs K-组0.51%(OR 1.33,95%CI 0.63-2.81,P=0.451)。
  • 其他分析均未发现围手术期酮咯酸给药与因出血再手术存在关联。

临床怎么用

  • 作者结论认为手术结束时使用酮咯酸可考虑作为儿童扁桃体切除术非阿片类镇痛方案的一部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if perioperative ketorolac is associated with an increased rate of reoperation for hemorrhage after pediatric tonsillectomy at 30 days and 48 hours. STUDY DESIGN: Single-center retrospective propensity-matched study. SETTING: Quaternary pediatric hospital and ambulatory surgery center. METHODS: Patients less than 18 years old undergoing tonsillectomy or adenotonsillectomy between January 1, 2015 and October 1, 2020 were included. Hemorrhage rates between exposed (K+) and unexposed (K-) patients were calculated for the total cohort and a 1:1 propensity-matched cohort. Additional analyses included: multivariable logistic regression, subgroup analysis of ASA 1 and 2 patients, subgroup analysis comparing children with teenagers. RESULTS: There were 5873 patients (42.1% K+) in the full cohort and 4694 patients in the propensity-matched cohort. Reoperation for hemorrhage within 30 days occurred in 1.9% of K+ patients and 1.6% of K- patients (P = 0.455) in the full cohort and 1.9% of K+ patients and 1.7% of K- patients (odds ratio [OR] 1.10, 95% confidence interval [CI] 0.72-1.69, P = 0.662) in the propensity-matched cohort. Reoperation within 48 hours occurred in 0.65% of K+ patients and 0.53% of K- patients (P = 0.679) in the full cohort and 0.68% of K+ patients and 0.51% of K- patients (OR 1.33, 95% CI 0.63-2.81, P = 0.451) in the propensity-matched cohort. There was no association between perioperative ketorolac administration and reoperation for hemorrhage in any of the other analyses. CONCLUSION: Ketorolac at end of surgery should be considered as part of the nonopioid analgesic regimen for pediatric tonsillectomy.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Feldman RM, O'Reilly-Shah V, Dahl JP, et al. Impact of Ketorolac on Reoperation for Hemorrhage After Pediatric Tonsillectomy: A Single-Center Retrospective Propensity-Matched Study. Otolaryngol Head Neck Surg. 2023. PMID: 37925621. doi:10.1002/ohn.577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。